Testosterone may speed up the growth of prostate cancer due to aromatase activity

BJU International

Volumn 106, Issue 3, 2010, Pages 434-

  Friedman, A Edward ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ALPHA REDUCTASE INHIBITOR; ANDROGEN RECEPTOR; ANDROSTANOLONE; AROMATASE; AROMATASE INHIBITOR; ESTROGEN RECEPTOR ALPHA; TESTOSTERONE; UNCLASSIFIED DRUG;

CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CLINICAL PROTOCOL; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR BINDING; TUMOR XENOGRAFT;

ANDROGENS; DIHYDROTESTOSTERONE; HUMANS; HYPOGONADISM; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TESTOSTERONE;

EID: 77955719499     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09526.x     Document Type: Letter

References (6)

1. Leibowitz RL, Dorff TB, Tucker S, Symanowski J, Vogelzand NJ. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms. BJU Int 2010 105 : 1397 1401
2. Wilbert DM, Griffin JE, Wilson JD. Characterization of the cytosol androgen receptor of the human prostate. J Clin Endocrinol Metab 1983 56 : 113 120
3. Hatzoglou A, Kampa M, Kogia C et al. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J Clin Endocrinol Metab 2005 90 : 893 903
4. Friedman AE. Can a single model explain both breast cancer and prostate cancer? Theor Biol Med Model 2007 4 : 28
5. Bonkhoff H, Berges R. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur Urol 2009 55 : 533 542
6. Umekita Y, Hiipakka RA, Kokontis JM, Liao S. Human prostate tumor growth in athymic mice: Inhibition by androgens and stimulation by finasteride. Proc Natl Acad Sci USA 1996 93 : 11802 11807